Guinness Atkinson Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Guinness Atkinson Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,400	Closed	-$279K	–	64
2017 Q2	$279K	Buy	8,400 +2,580	+44%	+$79.9K	0.18%	46
2017 Q1	$187K	Hold	5,820	–	–	0.12%	62
2016 Q4	$211K	Buy	5,820 +1,250	+27%	+$49.9K	0.14%	64
2016 Q3	$210K	Sell	4,570 -380	-8%	-$19.8K	0.13%	68
2016 Q2	$249K	Buy	4,950 +220	+5%	+$11.7K	0.16%	68
2016 Q1	$253K	Hold	4,730	–	–	0.16%	69
2015 Q4	$310K	Sell	4,730 -520	-10%	-$32.1K	0.18%	64
2015 Q3	$296K	Buy	+5,250	New	+$340K	0.19%	60

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Guinness Atkinson Asset Management's TEVA Position: Q3 2017 in Review

Guinness Atkinson Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 8,400 shares — an estimated $279K sold.

Guinness Atkinson Asset Management first reported a position in TEVA in Q3 2015 and held it in 8 quarters. The position peaked at $310K in Q4 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Guinness Atkinson Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Guinness Atkinson Asset Management sold 8,400 Teva Pharmaceuticals shares in Q3 2017, an estimated $279K.
Guinness Atkinson Asset Management first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 8 quarters.
Guinness Atkinson Asset Management's Teva Pharmaceuticals position peaked at $310K in Q4 2015.
535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Guinness Atkinson Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.